- Colon Capsule Endoscopy for Inflammatory Bowel Disease
-
Hosoe N, Hayashi Y, Ogata H
- KMID: 2507588
- Clin Endosc.
- 2020 Sep;53(5):550-554.
- doi: 10.5946/ce.2019.156
Colon capsule endoscopy was initially introduced in 2006. Since the results of a prospective study to evaluate first-generation colon capsule endoscopy efficacy for the detection of colonic neoplasia were unsatisfactory,... -
- CITED
-
- Close
- SHARE
-
- Close
- Application and Efficacy of Super-Magnifying Endoscopy for the Lower Intestinal Tract
-
Hosoe N, Ogata H
- KMID: 2166547
- Clin Endosc.
- 2016 Jan;49(1):37-40.
- doi: 10.5946/ce.2016.49.1.37
Endoscopy plays a significant role in the diagnosis, management, and surveillance of colorectal cancer (CRC) and inflammatory bowel diseases (IBDs). Moreover, magnifying endoscopy and image-enhanced endoscopy has a crucial role... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent trends in diagnostic techniques for inflammatory bowel disease
-
Naganuma M, Hosoe N, Kanai T, Ogata H
- KMID: 2160699
- Korean J Intern Med.
- 2015 May;30(3):271-278.
- doi: 10.3904/kjim.2015.30.3.271
Although ileocolonoscopy is the gold standard for diagnosis of inflammatory bowel disease and is useful for assessing the disease severity in the colon and terminal ileum, several alternative diagnostic techniques... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
-
Ogata H, Hagiwara T, Kawaberi T, Kobayashi M, Hibi T
- KMID: 2521605
- Intest Res.
- 2021 Oct;19(4):419-429.
- doi: 10.5217/ir.2020.00033
Background/Aims: Adalimumab has been shown to induce and maintain clinical remission in patients with moderate to severe ulcerative colitis (UC). However, no large-scale population-based studies have been performed in Japan.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
-
Ogata H, Ohori A, Nishino H, Mizushima , Hagino A, Hibi T
- KMID: 2382380
- Intest Res.
- 2017 Jul;15(3):358-367.
- doi: 10.5217/ir.2017.15.3.358
BACKGROUND/AIMS: This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission. METHODS: In this multicenter, randomized, double-blind study, 203 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
-
Ogata H, Yokoyama T, Mizushima , Hagino A, Hibi T
- KMID: 2417677
- Intest Res.
- 2018 Apr;16(2):255-266.
- doi: 10.5217/ir.2018.16.2.255
BACKGROUND/AIMS: This study compared the efficacy of multimatrix mesalazine 2.4 g/day and 4.8 g/day with controlled-release mesalazine 2.25 g/day. METHODS: In this multicenter, randomized, double-blind study, 251 patients with mildly to... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
-
Ogata H, Aoyama N, Mizushima , Hagino A, Hibi T
- KMID: 2382381
- Intest Res.
- 2017 Jul;15(3):368-379.
- doi: 10.5217/ir.2017.15.3.368
BACKGROUND/AIMS: This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) compared to another form of high-dose mesalazine. METHODS: In this multicenter, randomized, double-blind study, 280 patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- 5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
-
Miyoshi J, Matsuoka K, Yoshida A, Naganuma M, Hisamatsu , Yajima T, Inoue N, Okamoto S, Iwao Y, Ogata H, Ueno F, Hibi T, Kanai T
- KMID: 2434166
- Intest Res.
- 2018 Oct;16(4):635-640.
- doi: 10.5217/ir.2018.00015
Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of the Oral Administration of Mosapride Citrate on Capsule Endoscopy Completion Rate
-
Ida Y, Hosoe N, Imaeda H, Bessho R, Ichikawa R, Naganuma M, Kanai T, Hibi T, Ogata H
- KMID: 2053496
- Gut Liver.
- 2012 Jul;6(3):339-343.
BACKGROUND/AIMS: In capsule endoscopy (CE), the capsule does not always reach the cecum within its battery life, which may reduce its diagnostic yield. We evaluated the effect of mosapride citrate,... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
-
Aoki Y, Kiyohara H, Mikami Y, Nanki K, Kawaguchi T, Yoshimatsu Y, Sugimoto S, Sujino T, Takabayashi K, Hosoe N, Ogata H, Iwao Y, Kanai T
- KMID: 2544755
- Intest Res.
- 2023 Jul;21(3):318-327.
- doi: 10.5217/ir.2022.00116
Background/Aims: Thromboprophylaxis is recommended for hospitalized patients with inflammatory bowel disease (IBD) in Western countries, although it is selectively administered to high-risk patients in East Asia. A central venous catheter... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Enhanced Visibility in Evaluating Polyposis Syndromes Using a Newly Developed Contrast Image Capsule Endoscope
-
Hatogai K, Hosoe N, Imaeda H, Rey JF, Okada S, Ishibashi , Kimura K, Yoneno K, Usui S, Ida Y, Tsukada N, Kanai T, Hibi T, Ogata H
- KMID: 2284267
- Gut Liver.
- 2012 Apr;6(2):218-222.
BACKGROUND/AIMS: A flexible spectral imaging color enhancement system was installed in new capsule software for video capsule endoscopy. Contrast image capsule endoscopy (CICE) is a novel technology using light-emitting diodes... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn’s Disease: A Propensity Score-Matched Study
-
Takabayashi K, Hosoe N, Kato M, Hayash Y, Miyanaga R, Nanki K, Fukuhara K, Shinta Mizuno YM, Sujino T, Mutaguchi M, Naganuma M, Yahagi N, Ogata H, Kanai T, Mizuno S
- KMID: 2506436
- Gut Liver.
- 2020 Sep;14(5):619-625.
- doi: 10.5009/gnl19228
Background/Aims: The evaluation of small bowel lesions of Crohn’s disease (CD) using balloon-assisted enteroscopy (BAE) is crucial because mucosal healing is associated with a good prognosis. However, BAE procedures are... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
-
Hisamatsu T, Suzuki Y, Kobayashi M, Hagiwara T, Kawaberi T, Ogata H, Matsui T, Watanabe M, Hibi T
- KMID: 2521604
- Intest Res.
- 2021 Oct;19(4):408-418.
- doi: 10.5217/ir.2020.00025
Background/Aims: Crohn’s disease is a chronic disorder; therefore, it is essential to investigate long-term safety and efficacy of treatments. This study assessed the safety and effectiveness of adalimumab for up... -
- CITED
-
- Close
- SHARE
-
- Close
- Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study
-
Kim ES, Tae CH, Jung SA, Park DI, Im JP, Eun CS, Yoon H, Jang BI, Ogata H, Fukuhara K, Hirai F, Ohtsuka K, Liu J, Cao Q, on behalf of the Clinical Research Committee of the Asian Organization for Crohn’s and Colitis
- KMID: 2529565
- Intest Res.
- 2022 Apr;20(2):192-202.
- doi: 10.5217/ir.2020.00150
Background/Aims: Complementary and alternative medicine (CAM) is prevalent in East Asia. However, information on CAM in East Asian patients with inflammatory bowel disease (IBD) is scarce. We aimed to profile... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
-
Kobayashi , Hisamatsu , Suzuki Y, Ogata H, Andoh A, Araki T, Hokari R, Iijima H, Ikeuchi H, Ishiguro Y, Kato S, Kunisaki R, Matsumoto , Motoya S, Nagahori M, Nakamura S, Nakase H, Tsujikawa , Sasaki M, Yokoyama K, Yoshimura , Watanabe K, Katafuchi , Watanabe M, Hibi T
- KMID: 2417669
- Intest Res.
- 2018 Apr;16(2):168-177.
- doi: 10.5217/ir.2018.16.2.168
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international... -
- CITED
-
- Close
- SHARE
-
- Close
